clarithromycin has been researched along with clindamycin in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (5.71) | 18.7374 |
1990's | 16 (22.86) | 18.2507 |
2000's | 29 (41.43) | 29.6817 |
2010's | 19 (27.14) | 24.3611 |
2020's | 2 (2.86) | 2.80 |
Authors | Studies |
---|---|
Klugman, KP; Low, DE; Smith, AM; Wolter, N | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K | 1 |
Douthwaite, S; Farrell, DJ; Klugman, KP; Northwood, JB; Smith, AM; Wolter, N | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Arakawa, Y; Kimura, K; Nagano, N; Nagano, Y; Tamai, K; Yanagisawa, H | 1 |
Bohnert, JA; Fähnrich, E; Kern, WV; Schuster, S; Wehmeier, C | 1 |
Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
Brown-Elliott, BA; Nash, KA; Wallace, RJ | 1 |
Blackman Northwood, J; Coley, MD; Cossins, LR; Creti, R; Del Grosso, M; Farrell, DJ; Pantosti, A | 1 |
Iwata, S; Murayama, SY; Nakayama, E; Sakata, H; Seki, C; Sunakawa, K; Sunaoshi, K; Ubukata, K | 1 |
Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, KM; McGhee, P; Nagai, K | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Mima, T; Schweizer, HP | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Boothroyd, JC; Choi, JY; Fu, H; Harvey, C; Khosla, C; Lee, Y; Ravindran, S; Roush, WR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chen, J; Ding, C; Doyle, T; Duncan, L; Ebright, RH; He, S; Lin, W; Liu, Y; Lynch, AS; Ma, Z; Molodtsov, V; Nguyen, P; Pulse, M; Robertson, GT; Wang, H; Weiss, WJ; Xu, X; Yuan, Y; Zhuang, Z | 1 |
Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
Barry, AL; Jones, RN; Thornsberry, C | 2 |
Beaudette, FE; Benson, CA; Goodman, LJ; Hines, DW; Kaplan, RL; Segreti, J; Trenholme, GM | 1 |
Finegold, SM; Wexler, HM | 1 |
Debets-Ossenkopp, YJ; MacLaren, DM; Namavar, F | 1 |
Hughes, WT; Killmar, JT; Oz, HS | 1 |
Cardenal, C; Gatell, JM; Guelar, A; Mallolas, J; Miró, JM; Soriano, E; Zamora, L | 1 |
Chene, G; Dupon, M; Lacoste, D; Morlat, P; Pellegrin, JL; Ragnaud, JM | 1 |
Entenza, JM; Glauser, MP; Moreillon, P; Vermot, D; Vouillamoz, J | 1 |
Berg-Candolfi, M; Candolfi, E | 1 |
Gorodnitzky, Z; Korenman, Z; Weiss, I; Yagupsky, P | 1 |
Brookings, E; Gray, B; Swiatlo, E; Waites, K | 1 |
Brandt, CM; Miro, JM; Patel, R; Rouse, MS; Steckelberg, JM; Wilson, WR | 1 |
Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Hirakata, Y; Igari, J; Kaku, M; Matsuda, J; Misawa, N; Mori, T; Murase, M; Nakamura, A; Nakamura, Y; Oguri, T; Shimada, J; Shimoura, M; Shitara, M; Tachibana, Y; Tazawa, S; Ugajin, K; Umezu, S | 1 |
Kouppari, G; Mavroidi, A; Tzelepi, E; Tzouvelekis, LS; Zaphiropoulou, A | 1 |
Appelbaum, PC; Credito, KL; Ednie, LM; Jacobs, MR | 1 |
Benjamin, W; Crain, M; Edwards, K; Gray, B; Johnson, C; Waites, K | 1 |
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
Foustoukou, M; Ioannidou, S; Kotsovili-Tseleni, A; Legakis, NJ; Tassios, PT; Vatopoulos, A | 1 |
Cheng, B | 1 |
Bouvet, A; Broc, V; Merad, B; Rostane, H; Schlegel, L | 1 |
Appelbaum, PC; Bryskier, A; Davies, TA; Ednie, LM; Jacobs, MR; Nagai, K; Palavecino, E | 1 |
Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
Casal, M; Gordillo, RM; Ibarra, A; Lacasa, MJ; Rodríguez, F | 1 |
Bingen, E; Brahimi, N; Deforche, D; Doit, C; Francois, M; Mariani-Kurkdjian, P; Van den Abbeele, T | 1 |
Appelbaum, PC; Bozdogan, B; Clark, CL; Credito, KL; Ednie, LM; Jacobs, MR; Kelly, LM; Kosowska, K; Lin, G; Matic, V; McGhee, P; Pankuch, GA; Smith, K | 1 |
Shen, XZ; Wang, YH; Yang, H; Yang, YH; Yu, SJ; Yuan, L | 1 |
Balatsouras, DG; Homsioglou, E; Kouskoukis, C; Rallis, E; Verros, C | 1 |
Kardas, P; Muras, M | 1 |
Ardanuy, C; García-García, JJ; Gené, A; Palacín, E | 1 |
Amir, J; Bilavsky, E; Eliahou, R; Harel, L; Keller, N; Yarden-Bilavsky, H | 1 |
Fujieda, K; Makita, Y; Matsumoto, N; Sarashina, T; Tachibana, Y; Takahashi, S; Toriumi, N | 1 |
Chang, CL; Choi, GE; Kang, JE; Kim, JM; Kim, KH; Lee, EY; Tateda, K; Yamaguchi, K | 1 |
Andersen, LP; Berg, D; Jonaitis, L; Jørgensen, M; Kadusevicius, E; Kiudelis, G; Kupcinskas, J; Kupcinskas, L; Miciuleviciene, J; Rasmussen, L; Tamosiunas, V; Urbonaviciene, N | 1 |
Harada, Y; Hasegawa, H; Izumikawa, K; Kakeya, H; Kohno, S; Migiyama, Y; Morinaga, Y; Nagaoka, K; Nishimura, M; Yamada, K; Yanagihara, K | 1 |
Kasai, A; Nishiyama, H; Ogihara, S; Saito, R; Tanimichi, Y; Yamada, K | 1 |
Böttger, EC; Bruhn, DF; Lee, RE; Lenaerts, AJ; Liu, J; Meibohm, B; Scherbakov, D; Scherman, MS | 1 |
Fujii, R; Ishihara, K; Narita, M; Okuda, K; Shibahara, T; Takano, N | 1 |
Adams, E; Duchateau, T; Paul, P; Sänger-van de Griend, C; Van Schepdael, A | 1 |
Gergova, RT; Mitov, IG; Muhtarova, AA | 1 |
Alyabieva, NM; Katosova, LK; Khokhlova, TA; Lazareva, AV; Ponomarenko, OA | 1 |
Adam, HJ; Baxter, MR; Demczuk, W; Gilmour, MW; Golden, AR; Hoban, DJ; Karlowsky, JA; Martin, I; Mulvey, MR; Nichol, KA; Zhanel, GG | 1 |
Baddour, LM; Dayer, MJ; Durkin, MJ; Lockhart, PB; Thornhill, MH | 1 |
Conde-Agudelo, A; Garcia Sánchez, ÁJ; Jung, EJ; Romero, R | 1 |
2 review(s) available for clarithromycin and clindamycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Management of clinical chorioamnionitis: an evidence-based approach.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antioxidants; Antipyretics; Ceftriaxone; Cesarean Section; Chorioamnionitis; Clarithromycin; Clindamycin; Delivery, Obstetric; Endometritis; Evidence-Based Medicine; Female; Gentamicins; Gestational Age; Humans; Magnesium Sulfate; Metronidazole; Practice Guidelines as Topic; Pregnancy; Puerperal Infection; Tocolytic Agents | 2020 |
68 other study(ies) available for clarithromycin and clindamycin
Article | Year |
---|---|
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Drug Resistance, Bacterial; Genotype; Humans; Ketolides; Methyltransferases; Microbial Sensitivity Tests; Mutation; Phenotype; Pneumococcal Infections; Ribosomal Proteins; Streptococcus pneumoniae | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2007 |
Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation.
Topics: 5' Untranslated Regions; Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Ketolides; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; RNA, Ribosomal; Sequence Deletion; Streptococcus pneumoniae | 2008 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Female; Genetic Heterogeneity; Humans; Infant, Newborn; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Phylogeny; Sequence Analysis, DNA; Streptococcus agalactiae | 2008 |
Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Macrolides; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Sequence Homology, Amino Acid | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.
Topics: Amino Acid Sequence; Clarithromycin; Drug Resistance, Bacterial; Humans; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium chelonae; Nontuberculous Mycobacteria; Polymerase Chain Reaction; RNA | 2009 |
Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Bacterial; Global Health; Humans; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Population Surveillance; Respiratory Tract Infections; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus pyogenes | 2009 |
Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.
Topics: Adolescent; Adult; Aged; Bacterial Capsules; Child; Child, Preschool; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Polymerase Chain Reaction; Streptococcus agalactiae | 2009 |
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Macrolides; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Chemistry and biology of macrolide antiparasitic agents.
Topics: Anti-Bacterial Agents; Antiparasitic Agents; Cells, Cultured; Humans; Macrolides; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Toxoplasma | 2011 |
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Topics: Anaerobiosis; DNA-Directed RNA Polymerases; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Rifamycins | 2022 |
Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.
Topics: Anti-Bacterial Agents; Clarithromycin; Clindamycin; Erythromycin; Gram-Positive Bacteria; Humans; Macrolides; Microbial Sensitivity Tests; Neoplasms; Roxithromycin; Sepsis | 1990 |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin.
Topics: Azithromycin; Bacteria; Clarithromycin; Clindamycin; Culture Media; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Hydrogen-Ion Concentration; Leucomycins | 1988 |
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.
Topics: Anti-Bacterial Agents; Campylobacter fetus; Clarithromycin; Clindamycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 1987 |
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Clarithromycin; Clindamycin; Culture Media; Erythromycin; Leucomycins; Microbial Sensitivity Tests | 1987 |
Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteria.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Cefotaxime; Cefoxitin; Chloramphenicol; Clarithromycin; Clindamycin; Erythromycin; Microbial Sensitivity Tests | 1987 |
Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Spectinomycin | 1995 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Naphthoquinones; Pentamidine; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Atovaquone; Clarithromycin; Clindamycin; Drug Therapy, Combination; Folic Acid; Humans; Male; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Cerebral | 1994 |
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Drug Therapy, Combination; Female; France; Humans; Leucovorin; Male; Middle Aged; Pyrimethamine; Recurrence; Retrospective Studies; Sulfadiazine; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral | 1993 |
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Clindamycin; Colony Count, Microbial; Endocarditis, Bacterial; Erythromycin; Rats; Serum Bactericidal Test; Streptococcal Infections | 1996 |
Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Azithromycin; Clarithromycin; Clindamycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Intestinal Mucosa; Jejunum; Kinetics; Mice; Microsomes; Microsomes, Liver; Oxidoreductases, N-Demethylating; Reference Values; Time Factors; Toxoplasmosis, Animal | 1996 |
Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel.
Topics: Anti-Bacterial Agents; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Israel; Penicillins; Streptococcal Infections; Streptococcus pyogenes | 1997 |
In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment.
Topics: Administration, Oral; Adult; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Child; Clarithromycin; Clindamycin; Culture Media; Humans; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Clarithromycin; Clindamycin; Endocarditis, Bacterial; Erythromycin; Rabbits; Streptococcus | 1997 |
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Erythromycin; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Roxithromycin; Streptococcus pneumoniae | 1997 |
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin; Streptococcus pneumoniae | 1997 |
[Antimicrobial activities of roxithromycin against recently obtained clinical isolates].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Leucomycins; Methicillin Resistance; Miocamycin; Moraxella catarrhalis; Mycoplasma pneumoniae; Penicillin Resistance; Penicillins; Roxithromycin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 1997 |
Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Greece; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Phenotype; Streptococcus | 1999 |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; beta-Lactamases; Clarithromycin; Clindamycin; Drug Therapy, Combination; Erythromycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Ketolides; Macrolides; Metronidazole; Microbial Sensitivity Tests; Roxithromycin; Virginiamycin | 1999 |
Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children.
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Humans; Methyltransferases; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Greece; Humans; Infant; Male; Microbial Sensitivity Tests; Oropharynx; Phenotype; Rifampin; Streptococcus; Tetracycline; Vancomycin; Virginiamycin | 2001 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine | 1995 |
In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Colony Count, Microbial; Drug Resistance, Microbial; Erythromycin; France; Humans; Josamycin; Leucomycins; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Roxithromycin; Streptococcus pyogenes | 2001 |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae an
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptococcus pyogenes | 2001 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2000 |
[Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
Topics: Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillins; Pharyngitis; Spain; Streptococcal Infections; Streptococcus pyogenes | 2003 |
[Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; France; Humans; Macrolides; Penicillins; Streptococcal Infections; Streptococcus pyogenes | 2004 |
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Ketolides; Macrolides; Microbial Sensitivity Tests; Mutation; Streptococcus pneumoniae; Time Factors | 2004 |
[Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing].
Topics: Anti-Bacterial Agents; Child; China; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; Penicillins; Phenotype; Spiramycin; Streptococcal Infections; Streptococcus pneumoniae | 2004 |
Drug eruptions in children with ENT infections.
Topics: Acetaminophen; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Child; Child, Preschool; Clarithromycin; Clindamycin; Diagnosis, Differential; Drug Eruptions; Erythromycin; Female; Humans; Infant; Infections; Male; Otitis; Otorhinolaryngologic Diseases; Pharyngitis; Prospective Studies; Rhinitis; Risk Factors; Sinusitis; Stomatognathic Diseases; Tonsillitis | 2006 |
[A blinded comparison of palatability of 13 common pediatric antibiotic suspensions].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Clavulanic Acid; Clindamycin; Double-Blind Method; Female; Humans; Male; Patient Compliance; Pediatrics; Penicillins; Respiratory Tract Infections; Suspensions; Taste; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
[Increasing methylase-mediated resistance to macrolides in Streptococcus pyogenes in a children's hospital in Barcelona (Spain)].
Topics: Adolescent; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Hospitals, Pediatric; Humans; Infant; Macrolides; Membrane Proteins; Methyltransferases; Spain; Streptococcal Infections; Streptococcus pyogenes | 2006 |
Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Child; Clarithromycin; Clindamycin; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Israel; Male; Microbial Sensitivity Tests; Mouth; Penicillin G Benzathine; Rheumatic Fever; Rifampin; Secondary Prevention; Streptococcal Infections; Viridans Streptococci | 2008 |
Acute disseminated encephalomyelitis in an infant with incontinentia pigmenti.
Topics: Clarithromycin; Clindamycin; Diagnosis, Differential; Electroencephalography; Encephalomyelitis, Acute Disseminated; Female; Humans; Incontinentia Pigmenti; Infant; Magnetic Resonance Imaging; Methylprednisolone; Mycoplasma Infections; Mycoplasma pneumoniae; Reverse Transcriptase Polymerase Chain Reaction; Seizures | 2009 |
[Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients].
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Legionella; Legionellosis; Microbial Sensitivity Tests; Naphthyridines | 2010 |
Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lithuania; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Tetracycline | 2013 |
Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells.
Topics: Azithromycin; Cell Line; Clarithromycin; Clindamycin; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Fusobacterium nucleatum; Humans; Macrolides; Metronidazole; Mucin 5AC; Reverse Transcriptase Polymerase Chain Reaction | 2013 |
Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Japan; Microbial Sensitivity Tests; Moraxella catarrhalis; Moraxellaceae Infections; Mutation; RNA, Ribosomal, 23S | 2015 |
In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics.
Topics: Acute Disease; Animals; Antitubercular Agents; Clarithromycin; Clindamycin; Disease Models, Animal; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; Half-Life; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2015 |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions.
Topics: Actinomyces; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Campylobacter; Cefmetazole; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fusobacteria; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Ofloxacin; Periapical Periodontitis; Porphyromonas; Propionibacterium; Staphylococcus hominis; Veillonella | 2016 |
Capillary electrophoresis with capacitively coupled contactless conductivity detection method development and validation for the determination of azithromycin, clarithromycin, and clindamycin.
Topics: Azithromycin; Clarithromycin; Clindamycin; Electric Conductivity; Electrophoresis, Capillary | 2017 |
Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Proteins; Bulgaria; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Macrolides; Male; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Multiplex Polymerase Chain Reaction; Streptococcal Infections; Streptococcus pyogenes; Young Adult | 2017 |
Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Child; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Ear, Middle; Erythromycin; Female; Gene Expression; Genotype; Humans; Male; Membrane Proteins; Methylation; Microbial Sensitivity Tests; Nasopharynx; Phenotype; Ribosomes; Streptococcal Infections; Streptococcus pyogenes; Vagina | 2016 |
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Canada; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Risk Factors; Streptococcus pneumoniae; Young Adult | 2018 |
Risk of Adverse Reactions to Oral Antibiotics Prescribed by Dentists.
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clindamycin; Dentists; England; Humans; Metronidazole; Penicillins | 2019 |